ARCHIVES

In Brief: Pittsburgh Joins List Of Comprehensive Center Prospect; FDA Schedules Meeting On Cancer Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 28 | July 11, 1975

Download PDF Visit The Full Archive

Related Articles

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

March 28, 2014

House: NCI Should Coordinate National Cancer Program

August 4, 1995

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

In Brief: No Decision Yet On How CALB Cuts Will Be Made; Wyngaarden Of Duke Will Be New Director of NIH

January 29, 1982

(8-page issue)

November 2, 2002

Cancer Death Rates Declined 2.1 Percent Per Year.

October 19, 2007